US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition

2 years ago 35
ARTICLE AD BOX
The Federal Trade Commission is challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic
Read Entire Article